DK0779076T3 - Peptid, en fremgangsmåde til fremstilling af det og en farmaceutisk forbindelse baseret på det - Google Patents

Peptid, en fremgangsmåde til fremstilling af det og en farmaceutisk forbindelse baseret på det

Info

Publication number: DK0779076T3
Authority: DK; Denmark
Prior art keywords: cys; ala; peptide; orn; lys
Prior art date: 1994-06-29

Application number

DK95924554T

Other languages

English (en)

Inventor

Vladislav Isakovich Deigin

Elena Petrovna Yarova

Original Assignee

Immunotech Dev Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-29

Filing date

1995-06-27

Publication date

2005-07-11

1995-06-27 Application filed by Immunotech Dev Inc filed Critical Immunotech Dev Inc

2005-07-11 Application granted granted Critical

2005-07-11 Publication of DK0779076T3 publication Critical patent/DK0779076T3/da

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
150000001875 compounds Chemical class 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
-1 D-Hyp Chemical compound 0.000 abstract 12
AHLPHDHHMVZTML-SCSAIBSYSA-N D-Ornithine Chemical compound NCCC[C@@H](N)C(O)=O AHLPHDHHMVZTML-SCSAIBSYSA-N 0.000 abstract 3
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 3
ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 abstract 3
KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 abstract 3
DCXYFEDJOCDNAF-UWTATZPHSA-N D-Asparagine Chemical compound OC(=O)[C@H](N)CC(N)=O DCXYFEDJOCDNAF-UWTATZPHSA-N 0.000 abstract 2
XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 abstract 2
AGPKZVBTJJNPAG-RFZPGFLSSA-N D-Isoleucine Chemical compound CC[C@@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-RFZPGFLSSA-N 0.000 abstract 2
CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 abstract 2
ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 abstract 2
MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 abstract 2
QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 2
CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 abstract 2
WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 abstract 2
HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 abstract 2
ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 abstract 2
FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 abstract 2
COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 abstract 2
AYFVYJQAPQTCCC-STHAYSLISA-N D-threonine Chemical compound C[C@H](O)[C@@H](N)C(O)=O AYFVYJQAPQTCCC-STHAYSLISA-N 0.000 abstract 2
QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 abstract 2
OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 abstract 2
KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 abstract 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 2
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 2
150000001408 amides Chemical class 0.000 abstract 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
OABOXRPGTFRBFZ-IMJSIDKUSA-N Cys-Cys Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(O)=O OABOXRPGTFRBFZ-IMJSIDKUSA-N 0.000 abstract 1
ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 abstract 1
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 abstract 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
206010052428 Wound Diseases 0.000 abstract 1
208000027418 Wounds and injury Diseases 0.000 abstract 1
230000001195 anabolic effect Effects 0.000 abstract 1
150000008064 anhydrides Chemical class 0.000 abstract 1
UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 abstract 1
230000001764 biostimulatory effect Effects 0.000 abstract 1
230000037396 body weight Effects 0.000 abstract 1
239000003054 catalyst Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
238000010276 construction Methods 0.000 abstract 1
108010004073 cysteinylcysteine Proteins 0.000 abstract 1
210000002615 epidermis Anatomy 0.000 abstract 1
150000002170 ethers Chemical class 0.000 abstract 1
230000035876 healing Effects 0.000 abstract 1
230000000945 opiatelike Effects 0.000 abstract 1
229910052763 palladium Inorganic materials 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1
230000008439 repair process Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)

DK95924554T 1994-06-29 1995-06-27 Peptid, en fremgangsmåde til fremstilling af det og en farmaceutisk forbindelse baseret på det DK0779076T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
RU9494024278A RU2067000C1 (ru)	1994-06-29	1994-06-29	Пептид и способ его получения
PCT/RU1995/000138 WO1996002267A1 (en)	1994-06-29	1995-06-27	Peptide, a method of obtaining it and a pharmaceutical compound based on it

Publications (1)

Publication Number	Publication Date
DK0779076T3 true DK0779076T3 (da)	2005-07-11

Family

ID=20157803

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95924554T DK0779076T3 (da)	1994-06-29	1995-06-27	Peptid, en fremgangsmåde til fremstilling af det og en farmaceutisk forbindelse baseret på det

Country Status (12)

Country	Link
EP (1)	EP0779076B1 (da)
JP (1)	JP3668950B2 (da)
CN (1)	CN1165336C (da)
AT (1)	ATE290547T1 (da)
AU (1)	AU693576B2 (da)
CA (1)	CA2193969C (da)
DE (1)	DE69534061T2 (da)
DK (1)	DK0779076T3 (da)
ES (1)	ES2239760T3 (da)
PT (1)	PT779076E (da)
RU (1)	RU2067000C1 (da)
WO (1)	WO1996002267A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5868728A (en) *	1995-02-28	1999-02-09	Photogenesis, Inc.	Medical linear actuator for surgical delivery, manipulation, and extraction
RU2107691C1 (ru) *	1995-03-02	1998-03-27	Дейгин Владислав Исакович	Пептид и способ его получения
WO1997000889A1 (en) *	1995-06-21	1997-01-09	Asahi Kasei Kogyo Kabushiki Kaisha	Peptides binding to low-density lipoproteins
EP0861849A4 (en) *	1995-09-11	1999-05-26	Daiichi Seiyaku Co	PEPTIDE DERIVATIVES
US5965701A (en) *	1997-12-23	1999-10-12	Ferring Bv	Kappa receptor opioid peptides
JP2002535302A (ja)	1999-01-22	2002-10-22	ファーマコア，インコーポレイテッド	化学式１の化合物およびその誘導体の合成方法
US7473426B2 (en)	2001-02-27	2009-01-06	Yun Seok Choe	Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract
US20040101934A1 (en) *	2001-02-27	2004-05-27	Choe Yun Seok	Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and preparing process thereof
RU2298921C1 (ru) *	2005-10-04	2007-05-20	Закрытое Акционерное Общество "Центр "Пептос"	Способ стимуляции развития осетровых рыб
US8236766B2 (en)	2006-11-10	2012-08-07	Cara Therapeutics, Inc.	Uses of synthetic peptide amides
US7842662B2 (en)	2006-11-10	2010-11-30	Cara Therapeutics, Inc.	Synthetic peptide amide dimers
US7713937B2 (en)	2006-11-10	2010-05-11	Cara Therapeutics, Inc.	Synthetic peptide amides and dimeric forms thereof
US8906859B2 (en)	2006-11-10	2014-12-09	Cera Therapeutics, Inc.	Uses of kappa opioid synthetic peptide amides
MX2009005000A (es)	2006-11-10	2009-10-12	Cara Therapeutics Inc	Amidas de peptidos sinteticos.
JP6626446B2 (ja) *	2013-12-27	2019-12-25	ステルスバイオセラピューティックスコープ	薬学的に適切な芳香族カチオン性ペプチド
US10633415B2 (en)	2015-03-06	2020-04-28	Stealth Biotherapeutics Corp	Processes for preparing pharmaceutically relevant peptides
JP6134081B1 (ja) *	2015-12-10	2017-05-24	株式会社メニコン	ペプチド組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8005121A (nl) *	1979-09-20	1981-03-24	Erba Farmitalia	Biologisch actieve peptiden.
IE56021B1 (en) *	1982-10-13	1991-03-27	Akzo Nv	Peptides
JPS59181293A (ja) *	1983-03-31	1984-10-15	Kyowa Hakko Kogyo Co Ltd	新規生理活性蛋白性物質
FR2546756B1 (fr) *	1983-06-03	1985-11-29	Centre Nat Rech Scient	Nouveaux derives immunostimulants, leur preparation et leur application comme medicament
GB2146026A (en) *	1983-09-07	1985-04-11	Tanabe Seiyaku Co	Peptides and process for preparing the same
DE3435727A1 (de) *	1984-09-28	1986-04-10	Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl	Pharmakologisch aktive peptide
DE3841761A1 (de) *	1988-12-12	1990-06-13	Basf Ag	Neue tnf-peptide
DE3841763A1 (de) *	1988-12-12	1990-06-13	Basf Ag	Neue tnf-peptide
SE9300012D0 (sv) *	1993-01-05	1993-01-05	Astra Ab	New peptides

1994
- 1994-06-29 RU RU9494024278A patent/RU2067000C1/ru active
1995
- 1995-06-27 AU AU29002/95A patent/AU693576B2/en not_active Ceased
- 1995-06-27 ES ES95924554T patent/ES2239760T3/es not_active Expired - Lifetime
- 1995-06-27 AT AT95924554T patent/ATE290547T1/de not_active IP Right Cessation
- 1995-06-27 DK DK95924554T patent/DK0779076T3/da active
- 1995-06-27 JP JP50356096A patent/JP3668950B2/ja not_active Expired - Fee Related
- 1995-06-27 WO PCT/RU1995/000138 patent/WO1996002267A1/ru not_active Ceased
- 1995-06-27 DE DE69534061T patent/DE69534061T2/de not_active Expired - Lifetime
- 1995-06-27 EP EP95924554A patent/EP0779076B1/en not_active Expired - Lifetime
- 1995-06-27 CN CNB951943820A patent/CN1165336C/zh not_active Expired - Fee Related
- 1995-06-27 PT PT95924554T patent/PT779076E/pt unknown
- 1995-06-27 CA CA2193969A patent/CA2193969C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1159758A (zh)	1997-09-17
CA2193969C (en)	2010-11-30
EP0779076A4 (en)	1999-03-17
ATE290547T1 (de)	2005-03-15
EP0779076A1 (en)	1997-06-18
EP0779076B1 (en)	2005-03-09
JP3668950B2 (ja)	2005-07-06
PT779076E (pt)	2005-07-29
AU2900295A (en)	1996-02-16
JP2001503011A (ja)	2001-03-06
DE69534061D1 (de)	2005-04-14
CA2193969A1 (en)	1996-02-01
AU693576B2 (en)	1998-07-02
HK1012551A1 (en)	1999-08-06
RU2067000C1 (ru)	1996-09-27
CN1165336C (zh)	2004-09-08
ES2239760T3 (es)	2005-10-01
DE69534061T2 (de)	2006-04-13
WO1996002267A1 (en)	1996-02-01

Publication	Publication Date	Title
DK0779076T3 (da)	2005-07-11	Peptid, en fremgangsmåde til fremstilling af det og en farmaceutisk forbindelse baseret på det
KR0139632B1 (ko)	1998-07-01	브라디키닌 길항 작용을 갖는 펩티드
UA48974C2 (uk)	2002-09-16	Пептид і спосіб його одержання
RU94024278A (ru)	1997-11-10	Пептид и способ его получения
RU95108559A (ru)	1997-08-27	Пептид и способ его получения
KR840002772A (ko)	1984-07-16	뇌하수체 성장호르몬 유리작용을 지닌 펩타이드의 합성방법
LV11993A (lv)	1998-03-20	Peptidi un to iegusanas panemiens
IE65356B1 (en)	1995-10-18	Peptides having bradykinin antagonist action
US4652627A (en)	1987-03-24	Calcitonin analogs with C-terminal D-amino acid substituents
KR910009730A (ko)	1991-06-28	펩티드
RU2006111491A (ru)	2007-11-20	Новые противоопухолевые соединения
FR2364889A1 (fr)	1978-04-14	Nouveaux derives encephaliniques a la methionine
ES536117A0 (es)	1985-08-01	Un procedimiento para preparar heptapeptidos y hexapeptidos ciclicos antagonistas de la vasopresina
EP0189326A3 (en)	1988-10-26	Derivatives of arginine vasopressin antagonists
EP0175323A2 (en)	1986-03-26	Biologically active peptides, processes for preparing them and pharmaceutical compositions
JPWO2022204305A5 (da)	2025-04-01
TH2820B (th)	1992-03-09	เพพไทด์สังเคราะห์ที่แสดงฤทธิ์ปลดปล่อยฮอร์โมนช่วยการเติบโตของพิทูอิทารี
TH1762A (th)	1984-09-03	เพพไทด์สังเคราะห์ที่แสดงฤทธิ์ปลดปล่อยฮอร์โมนช่วยการเติบโตของพิทูอิทารี